Skip to content

Effect of Ayarij-e-Faiqra on functional constipation

Effect of Ayarij-e-Faiqra on functional constipation in adults referring to Clinic

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200303046677N1
Enrollment
80
Registered
2020-05-05
Start date
2014-04-21
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation. Constipation

Interventions

Intervention 1: Intervention group: Ayarij-e-Faiqra. AF was prepared according to the “Qarabadin Kabir” textbook. prepared under the supervision of the professors of pharmacy of the Faculty of Traditi

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: The ability to participate in the whole study Absence of significant behavioral disorders Speech in understandable language Completion of the consent form and having at least six months of history of constipation according to Rome III criteria.

Exclusion criteria

Exclusion criteria: Sensitivity to herbal medicines Diagnosis of obstructive constipation by a gastroenterologist based on history or colon transit Consumption drugs that cause constipation in the recent month (anticholinergic drugs, tricyclic antidepressants, calcium channel blockers, anti-Parkinson's drugs, sympathomimetics, antipsychotics, diuretics, iron supplements, anti-inflammatory drugs, hormonal drugs) Abuse narcotics, stimulants, cannabis, alcohol and pseudo pirates Illnesses affecting constipation Warning signs (rectal bleeding, weight loss or anemia) Unpredictable complications were leading to intolerance to the drug or placebo such as idiosyncratic disease Secondary constipation to diseases, and medications Gastrointestinal complications that impede the continuation of the study Unwilling to continue the study and lack of cooperation.

Design outcomes

Primary

MeasureTime frame
Straining during at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Lumpy or hard stools in at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;The sensation of incomplete evacuation for at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Sensation of anorectal obstruction/blockage for at least 25% of defecations. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Manual maneuvers to facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor). Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Fewer than three defecations per week. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Loose stools are rarely present without the use of laxatives. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: A questionnaire filled out by the researcher using the interview method.;Patient satisfaction. Timepoint: The end of 1, 2, 3 months, and three months after the end of the intervention. Method of measurement: Using the visual analogue scale questionnaire, ten scores were filled in by the researcher using t

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Choopani

Shahid Beheshti University of Medical Sciences

rchoopani@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026